Nature Publishing Group, publisher of Nature, and other science journals and reference works about npg naturejobs natureevents help site index
my accounte-alertssubscriberegister
SEARCH JOURNAL   advanced search
Monday 12 March 2018
Journal Home
Table of Contents
Feature of the Week
The Nature top ten
Tech Features
For Authors
About Nature
Contact Nature
Asia gateway
German gateway
Japan gateway
  Vol 426 No 6968 (Insight) pp883-909

18/25 December 2003

  review articles

protein misfolding

Adam Smith Editor, Nature Reviews Drug Discovery

At school it all sounded so simple — transcription turns DNA into RNA, and translation of RNA gives you protein. But the often forgotten third step in this process, the folding of the translated linear strand of amino acids into a fully functional three-dimensional protein, is one of the most complex challenges facing the cellular protein factory.

Although it has long been known that the amino-acid sequence in some way dictates the biologically active conformation of a protein, the experimental tools required to probe the intermediate states along the folding pathway have only begun to become available in the past decade or so. These tools are revealing a tightly regulated assembly line, where multiple factors guide nascent proteins to select the correct shape from an almost infinite array of possibilities.

Becoming apparent are the stringent quality-control systems that come into play if the folding process fails, ensuring that the misfolded products are targeted for degradation before they cause harm. Those that escape this cellular surveillance are prone to forming aggregates that can damage or kill cells through mechanisms that are just beginning to be understood.

A huge variety of previously unrelated diseases, such as prion diseases, diabetes and cancer, share the pathological feature of aggregated misfolded protein deposits. This suggests the exciting possibility that these 'protein-misfolding diseases' are linked by common principles, and may therefore present common targets for therapeutic intervention.

The articles in this Insight give an interdisciplinary overview of the field of protein-folding research, treading a path from protein chemistry through cell biology to misfolding diseases and the potential for therapeutic development.

This Insight is entirely self-contained; however, its scope and focus were mirrored in the organization of last year's Horizon Symposium on 'Protein Folding and Disease', the first in a new series of discussion meetings created as a joint initiative by Nature Publishing Group and Aventis. Complementary material can therefore be found at

  protein misfolding 883
Full text | PDF (484k)
 review articles
  Protein folding and misfolding 884
Summary | Full text | PDF (448k)
  Quality control in the endoplasmic reticulum protein factory 891
Summary | Full text | PDF (239k)
 review articles
  Protein degradation and protection against misfolded or damaged proteins 895
Summary | Full text | PDF (195k)
  Folding proteins in fatal ways 900
Summary | Full text | PDF (216k)
  Therapeutic approaches to protein-misfolding diseases 905
Summary | Full text | PDF (238k)
Back to main issue
Home | Table of Contents | Advance Online Publication | Archive | Highlights | Feature of the Week
The Nature top ten | Insights | Tech Features | Authors | Permissions
About Nature | Advertising | Contact Nature
© 2003 Nature Publishing Group
Privacy Policy